6th Circ. Affirms Toss Of Generic Drug Labeling Suits

Law360, New York (September 22, 2011, 6:51 PM EDT) -- The Sixth Circuit on Thursday upheld the dismissal of three suits bringing state failure-to-warn claims related to generic versions of heartburn medication Reglan against Barr Pharmaceuticals Inc. and others, citing the U.S. Supreme Court's recent decision in Pliva Inc. v. Mensing.

A three-judge panel ruled that a Western District of Kentucky judge had correctly decided in 2008 to nix three suits accusing both generic-drug makers as well as the drug's brand-name manufacturers of failing to include adequate information on their product labels concerning the risk that...
To view the full article, register now.